Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Grundt

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondiiBogdana Krivogorsky, Jennifer A Pernat, Kelsi A Douglas, et al.
Journal of Medicinal Chemistry|June 11, 2004
Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluationSantosh S Kulkarni, Peter Grundt, Theresa Kopajtic, et al.
Synapse (New York, N.Y.)|November 20, 2009
Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathwaysMichelle Taylor, Peter Grundt, Suzy A Griffin, et al.
Journal of Medicinal Chemistry|April 4, 2003
14-amino, 14-alkylamino, and 14-acylamino analogs of oxymorphindole. Differential effects on opioid receptor binding and functional profilesPeter Grundt, Andrew R Jales, John R Traynor, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2006
Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SARPeter Grundt, Sarah Little Jane Husband, Robert R Luedtke, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 29, 2008
Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effectsGregory T Collins, Diane M Calinski, Amy Hauck Newman, et al.
Behavioural Pharmacology|June 23, 2011
Effects of selective dopaminergic compounds on a delay-discounting taskMikhail N Koffarnus, Amy H Newman, Peter Grundt, et al.
Organic & Biomolecular Chemistry|October 4, 2013
Is the 2,3-carbon-carbon bond of indole really inert to oxidative cleavage by Oxone?--synthesis of isatoic anhydrides from indolesAmber C Nelson, Emily S Kalinowski, Nikolas J Czerniecki, et al.
Neuropharmacology|April 18, 2009
Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in ratsRakesh Kumar, Lindsay Riddle, Suzy A Griffin, et al.
Neuropharmacology|September 21, 2010
Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in ratsLindsay R Riddle, Rakesh Kumar, Suzy A Griffin, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|March 20, 2012
Structure-activity studies of some berberine analogs as inhibitors of Toxoplasma gondiiBogdana Krivogorsky, Jennifer A Pernat, Kelsi A Douglas, et al.
Journal of Medicinal Chemistry|June 11, 2004
Structure-activity relationships at monoamine transporters for a series of N-substituted 3alpha-(bis[4-fluorophenyl]methoxy)tropanes: comparative molecular field analysis, synthesis, and pharmacological evaluationSantosh S Kulkarni, Peter Grundt, Theresa Kopajtic, et al.
Synapse (New York, N.Y.)|November 20, 2009
Dopamine D3 receptor selective ligands with varying intrinsic efficacies at adenylyl cyclase inhibition and mitogenic signaling pathwaysMichelle Taylor, Peter Grundt, Suzy A Griffin, et al.
Journal of Medicinal Chemistry|April 4, 2003
14-amino, 14-alkylamino, and 14-acylamino analogs of oxymorphindole. Differential effects on opioid receptor binding and functional profilesPeter Grundt, Andrew R Jales, John R Traynor, et al.
Bioorganic & Medicinal Chemistry Letters|November 11, 2006
Analogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SARPeter Grundt, Sarah Little Jane Husband, Robert R Luedtke, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 29, 2008
Food restriction alters N'-propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine dihydrochloride (pramipexole)-induced yawning, hypothermia, and locomotor activity in rats: evidence for sensitization of dopamine D2 receptor-mediated effectsGregory T Collins, Diane M Calinski, Amy Hauck Newman, et al.
Behavioural Pharmacology|June 23, 2011
Effects of selective dopaminergic compounds on a delay-discounting taskMikhail N Koffarnus, Amy H Newman, Peter Grundt, et al.
Organic & Biomolecular Chemistry|October 4, 2013
Is the 2,3-carbon-carbon bond of indole really inert to oxidative cleavage by Oxone?--synthesis of isatoic anhydrides from indolesAmber C Nelson, Emily S Kalinowski, Nikolas J Czerniecki, et al.
Neuropharmacology|April 18, 2009
Evaluation of the D3 dopamine receptor selective antagonist PG01037 on L-dopa-dependent abnormal involuntary movements in ratsRakesh Kumar, Lindsay Riddle, Suzy A Griffin, et al.
Neuropharmacology|September 21, 2010
Evaluation of the D3 dopamine receptor selective agonist/partial agonist PG01042 on L-dopa dependent animal involuntary movements in ratsLindsay R Riddle, Rakesh Kumar, Suzy A Griffin, et al.
Pageof 4